The Cyberabad traffic police conducted a special drunk driving enforcement drive over the weekend, resulting in the ...

In a major development for diabetes care in India, Dr. Reddy's Labs has got the go-ahead from the Subject Expert Committee ...

The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...

An unlicensed driver who drove drunk causing a deadly collision in Rexdale two years ago has been sentenced to four years in ...

Nerandomilast, marketed as Jascayd by its manufacturer Boehringer Ingelheim, is the first therapy approved in more than 10 ...

Telangana DCA raids unlicensed premises selling illegal prescription drugs, warns of severe health risks from misuse of ...

At least 15 people were sentenced to jail for driving in an inebriated condition in Cyberabad limits. The Cyberabad traffic ...

The company is going make USD 250 million investment for new state-of-the art manufacturing facility in Coral ...

The health risks for children younger than two years of age are severe — from toxicity to respiratory depression, said ...

Brensocatib effectively reduces NSP activity in bronchiectasis patients, with greater reductions observed in the 25-mg dose group compared to the 10-mg group.

Deflazacort oral suspension is indicated for the treatment of Duchenne Muscular Dystrophy (DMD) in patients aged five years and older. Shares of Zydus Lifesciences Ltd ended at ₹994.55, up by ₹5.80, ...